Glaxo invests $50 million in biotech startups to develop new medicine
GlaxoSmithKline will invest $50 million in a $250 million venture to help early-stage biotechnology companies develop new medicines.
Read more:
Glaxo invests $50 million in biotech startups to develop new medicine
Leave a Reply
You must be logged in to post a comment.
View video inside